Genocea Biosciences

YTD

ALL

Why Robinhood?

You can watch GNCA and buy or sell other stocks, ETFs, and their options commission-free!

About GNCA

Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses.

CEO

Chip Clark, MBA

CEOChip Clark, MBA

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2006

Founded2006

Employees

—

Employees—

GNCA Key Statistics

Market cap

100.00

Market cap100.00

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.20

Average volume1.20

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.0001

52 Week high$0.0001

52 Week low

—

52 Week low—

Stock Snapshot

With a market cap of 100, Genocea Biosciences(GNCA) trades at $2.26.

During the trading day, Genocea Biosciences(GNCA) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Genocea Biosciences(GNCA) stock has reached 0, versus its average volume of 1.2.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.